Skip to main content

CRIMINAL JUSTICE - DRUG ABUSE TREATMENT STUDIES

Home
Phase I
Phase II
About
  
CRIMINAL JUSTICE - DRUG ABUSE TREATMENT STUDIES > Pages > Study - IPASS  

Study - IPASS

Inmate Pre-Release Assessment (IPASS)
        Lead Investigator: Michael Prendergast, PhD
  Co-Lead Investigator: David Farabee, PhD
  Lead Center: Pacific Coast Research Center (UCLA, Criminal Justice Research Group at Integrated Substance Abuse Programs)
  Collaborating Centers: Central States Research Center (University of Kentucky, Center on Drug and Alcohol Research)
Rhode Island Research Center (Brown University/Lifespan Hospital)
Southwest Research Center (Texas Christian University, Institute of Behavioral Research)
        Topics: Screening & Referral, Structured Reentry
 

Although at least two valid assessments currently exist to inform decisions regarding level of supervision for paroling offenders (e.g., Level of Services Inventory) or modality of treatment for substance abusers in the community (e.g., ASAM criteria), neither of these assessments was developed specifically for substance-abusing parolees who are encouraged or required to participate in treatment after they are released from prison.  The Inmate Pre-Release Assessment (IPASS) was developed specifically as a post-release risk measure for prison-based substance abuse treatment graduates by taking into account the inmates’ historical drug use and criminal activity as well as his or her performance during the prison-based treatment program.  The primary purpose of this study will be to:

  • Test the ability of the IPASS to predict relapse and recidivism using a prospective design.
  • Assess its use in matching offenders to a particular level of aftercare. 
Brief Report

Last modified at 10/15/2009 10:42 PM  by rickz 
NIHNIDA
© Copyright 2005, National Institute on Drug Abuse
A project of the National Institute on Drug Abuse, National Institutes of Health, and the U.S. Department of Health and Human Services. The work is supported by NIDA but the content does not necessarily represent the views of NIDA or any governmental agency.